These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 2202199)
21. Comparative, open, randomized trial of the efficacy and tolerance of slow-release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis: French Pentasa Study Group. Marteau P; Florent C Am J Gastroenterol; 2000 Jan; 95(1):166-70. PubMed ID: 10638577 [TBL] [Abstract][Full Text] [Related]
22. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial. Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408 [TBL] [Abstract][Full Text] [Related]
23. Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using 99mTc-labeled 5-ASA suppositories. Williams CN; Haber G; Aquino JA Dig Dis Sci; 1987 Dec; 32(12 Suppl):71S-75S. PubMed ID: 3319461 [TBL] [Abstract][Full Text] [Related]
24. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine. Habal FM; Greenberg GR Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391 [TBL] [Abstract][Full Text] [Related]
25. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Marshall JK; Irvine EJ Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961 [TBL] [Abstract][Full Text] [Related]
27. [5-aminosalicylic acid enema (Pentasa) versus hydrocortisone acetate foam (Proctocort) for the treatment of outbreaks of proctitis and cryptogenetic proctosigmoiditis. A comparative randomized multicenter trial]. Ngô Y; Rambaud JC Gastroenterol Clin Biol; 1992; 16(6-7):558-63. PubMed ID: 1526418 [TBL] [Abstract][Full Text] [Related]
28. Double-blind comparison of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid suppositories in patients with idiopathic proctitis. van Hogezand RA; van Hees PA; van Gorp JP; van Lier HJ; Bakker JH; Wesseling P; van Haelst UJ; van Tongeren JH Aliment Pharmacol Ther; 1988 Feb; 2(1):33-40. PubMed ID: 2979230 [TBL] [Abstract][Full Text] [Related]
29. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. Schroeder KW; Tremaine WJ; Ilstrup DM N Engl J Med; 1987 Dec; 317(26):1625-9. PubMed ID: 3317057 [TBL] [Abstract][Full Text] [Related]
30. Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies. Bosworth BP; Sandborn WJ; Rubin DT; Harper JR Inflamm Bowel Dis; 2016 Aug; 22(8):1881-6. PubMed ID: 27416045 [TBL] [Abstract][Full Text] [Related]
31. Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission. Ewe K; Becker K; Ueberschaer B Z Gastroenterol; 1996 Apr; 34(4):225-9. PubMed ID: 8686349 [TBL] [Abstract][Full Text] [Related]
32. Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis. Gross V; Bar-Meir S; Lavy A; Mickisch O; Tulassay Z; Pronai L; Kupcinskas L; Kiudelis G; Pokrotnieks J; Kovács A; Faszczyk M; Razbadauskas A; Margus B; Stolte M; Müller R; Greinwald R; Aliment Pharmacol Ther; 2006 Jan; 23(2):303-12. PubMed ID: 16393311 [TBL] [Abstract][Full Text] [Related]
33. Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis. Lindgren S; Löfberg R; Bergholm L; Hellblom M; Carling L; Ung KA; Schiöler R; Unge P; Wallin C; Ström M; Persson T; Suhr OB Scand J Gastroenterol; 2002 Jun; 37(6):705-10. PubMed ID: 12126250 [TBL] [Abstract][Full Text] [Related]
34. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Cohen RD; Woseth DM; Thisted RA; Hanauer SB Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of clinical patterns in ulcerative colitis: a long-term follow-up. Bresci G; Parisi G; Gambardella L; Banti S; Bertoni M; Rindi G; Capria A Int J Clin Pharmacol Res; 1997; 17(1):17-22. PubMed ID: 9403349 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of olsalazine (dipentum) in the treatment of patients with ulcerative colitis--results of a field study. Singer MV; Schmausser H; Schönfeld G Hepatogastroenterology; 2006; 53(69):317-21. PubMed ID: 16795963 [TBL] [Abstract][Full Text] [Related]
38. 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tabanelli GM; Miglioli M; Barbara L J Clin Gastroenterol; 1988 Aug; 10(4):406-9. PubMed ID: 3418088 [TBL] [Abstract][Full Text] [Related]
39. Ulcerative proctitis: a review of pharmacotherapy and management. Lakatos PL; Lakatos L Expert Opin Pharmacother; 2008 Apr; 9(5):741-9. PubMed ID: 18345952 [TBL] [Abstract][Full Text] [Related]
40. Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation -- a placebo-controlled study. Watanabe M; Nishino H; Sameshima Y; Ota A; Nakamura S; Hibi T Aliment Pharmacol Ther; 2013 Aug; 38(3):264-73. PubMed ID: 23734840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]